Cargando…

Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study

The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianjie, Zhou, Meilan, Chen, Zi, Chen, Cong, Wu, Gang, Zuo, Yingping, Ren, Xin, Chen, Zhuan, Wang, Weihua, Pang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078509/
https://www.ncbi.nlm.nih.gov/pubmed/32070443
http://dx.doi.org/10.1017/S0950268820000485
_version_ 1783507634735808512
author Wang, Jianjie
Zhou, Meilan
Chen, Zi
Chen, Cong
Wu, Gang
Zuo, Yingping
Ren, Xin
Chen, Zhuan
Wang, Weihua
Pang, Yu
author_facet Wang, Jianjie
Zhou, Meilan
Chen, Zi
Chen, Cong
Wu, Gang
Zuo, Yingping
Ren, Xin
Chen, Zhuan
Wang, Weihua
Pang, Yu
author_sort Wang, Jianjie
collection PubMed
description The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportional hazard regression analysis was used to evaluate the risk factors affecting survival. The total follow-up period was 270 person-years (PY) for 356 MDR-TB cases in Wuhan. Of the 356 cases, 103 patients died, yielding an average case fatality rate of 381.2 per 1000 TB patients per year. Using adjusted Cox regression analysis, older age (adjusted hazard ratio (aHR) >3.0 starting from 30 years) and low education level (primary and middle school; aHR 1.67 (95% CI 1.01–2.77)) were independently associated with lower survival. Diabetes mellitus profoundly affected the survival of MDR-TB patients (aHR 1.95 (95% CI 1.30–2.93)). Our data demonstrate that coexistent diabetes significantly and negatively impacted MDR-TB patient survival. In addition, MDR-TB patients aged 60 years or older exhibited a greater risk of mortality during follow-up. Our findings emphasise that MDR-TB patients with comorbidities that increase their risk of death require additional medical interventions to reduce mortality.
format Online
Article
Text
id pubmed-7078509
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-70785092020-03-23 Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study Wang, Jianjie Zhou, Meilan Chen, Zi Chen, Cong Wu, Gang Zuo, Yingping Ren, Xin Chen, Zhuan Wang, Weihua Pang, Yu Epidemiol Infect Original Paper The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportional hazard regression analysis was used to evaluate the risk factors affecting survival. The total follow-up period was 270 person-years (PY) for 356 MDR-TB cases in Wuhan. Of the 356 cases, 103 patients died, yielding an average case fatality rate of 381.2 per 1000 TB patients per year. Using adjusted Cox regression analysis, older age (adjusted hazard ratio (aHR) >3.0 starting from 30 years) and low education level (primary and middle school; aHR 1.67 (95% CI 1.01–2.77)) were independently associated with lower survival. Diabetes mellitus profoundly affected the survival of MDR-TB patients (aHR 1.95 (95% CI 1.30–2.93)). Our data demonstrate that coexistent diabetes significantly and negatively impacted MDR-TB patient survival. In addition, MDR-TB patients aged 60 years or older exhibited a greater risk of mortality during follow-up. Our findings emphasise that MDR-TB patients with comorbidities that increase their risk of death require additional medical interventions to reduce mortality. Cambridge University Press 2020-02-19 /pmc/articles/PMC7078509/ /pubmed/32070443 http://dx.doi.org/10.1017/S0950268820000485 Text en © Beijing Chest Hospital 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Wang, Jianjie
Zhou, Meilan
Chen, Zi
Chen, Cong
Wu, Gang
Zuo, Yingping
Ren, Xin
Chen, Zhuan
Wang, Weihua
Pang, Yu
Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title_full Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title_fullStr Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title_full_unstemmed Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title_short Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
title_sort survival of patients with multidrug-resistant tuberculosis in central china: a retrospective cohort study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078509/
https://www.ncbi.nlm.nih.gov/pubmed/32070443
http://dx.doi.org/10.1017/S0950268820000485
work_keys_str_mv AT wangjianjie survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT zhoumeilan survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT chenzi survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT chencong survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT wugang survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT zuoyingping survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT renxin survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT chenzhuan survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT wangweihua survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy
AT pangyu survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy